0%

Expectations of Alyftrek within the CF population

Information Sheet

Title of study: Expectations of Alyftrek within the Cystic Fibrosis population

You are being invited to participate in a research study. Before you make a decision on whether to take part, it is important for you to understand why the research is being done and what it will involve. Please read the following information carefully and discuss it with others if you wish. Please feel free to ask us any questions if there is anything that is not clear, or you would like more information on before you decide whether to participate or not. Thank you for reading.
 
Introduction to the research and invitation to take part
This study aims to investigate your attitudes, beliefs and expectations towards a new CFTR modulator therapy, Alyftrek, which has been approved by The National Institute for Health and Care Excellence (NICE). Participants are being recruited online via Facebook, X, Instagram, Discord and Reddit. In order to take part in this study you should be either:
·       An adult aged 18 years or above with a diagnosis of Cystic Fibrosis. You do not need to currently be taking a modulator therapy.
·       A parent / caregiver / spouse of an individual with Cystic Fibrosis. The individual with Cystic Fibrosis does not need to currently be taking a modulator therapy.
·       A healthcare professional who works within the Cystic Fibrosis population.
The members of the research team are: Dr Rebecca Keyte, and Prof. Helen Egan both of whom are researchers within Health Psychology at Birmingham City University.

What is the purpose of the study?
We are interested in individuals’ knowledge and views towards Alyftrek, particularly when reflecting on patients experiences with previous and current CFTR modulator therapies (e.g., Kaftrio). The findings from this research will be useful for health professionals to help support people with CF in terms of both physical and psychological wellbeing.

Do I have to take part?
It is up to you whether to take part or not. Participants are advised not to take part if they have a current mental health diagnosis and feel the topic of modulator therapies within Cystic Fibrosis may cause them distress.
You will complete this study online via QuestionPro on a date / time which is most convenient for yourself. To help you decide if you want to participate, you are welcome to contact the lead researcher (Dr Rebecca Keyte) via email (Rebecca.Keyte@bcu.ac.uk) or social media with any questions you may have.
If after reading this sheet and having any questions answered (via social media, email), you are still keen to participate, you will be asked to electronically sign the consent form. You are free to withdraw from this research at any time without giving a reason.

What will I have to do if I participate?
If you decide to participate, you will be asked to fill out a survey which elicits both closed and open-ended responses. There are a maximum of 17 questions to answer focusing on:
·       demographic questions
·       questions relating to previous / current experience with CFTR modulator therapies
·       The benefits you expect from Alyftrek for the Cystic Fibrosis population
·       Your concerns (if any) regarding Alyftrek for the Cystic Fibrosis population
This study will take about 20 minutes to complete; you will complete the study through the link provided on the social media advertisement. None of the information collected about you during this study will be seen by anyone including the staff treating you.

What are the possible risks of participating?
There is a potential for distress as you will be asked to discuss psychological wellbeing (e.g., mental health). If you feel that this could be a potential issue for you, you are advised not to take part in this research to decrease any potential risk of psychological harm. If you were to become distressed, you can leave the research at any time by closing the web browser. You do not have to answer any question you do not wish to.
Any information that you provide in this research will be strictly confidential. The information will be anonymised, which means that all identifying information will be removed.  

Are there any possible benefits?
There are likely to be no direct benefits to you by participating in this study. The findings from this research will be useful for health professionals to help support people with Cystic Fibrosis in this new era of healthcare.
If you do become distressed during the study or wish to discuss any information covered within the study with others, we advise you to discuss your feelings with your Cystic Fibrosis team. In addition, we advise you to contact the following organisations for support:

Cystic Fibrosis Trust: helpline@cysticfibrosis.org.uk or call 0300 373 1000 or 020 3795 2184 (the helpline is open 10am – 4pm Monday to Friday.

MIND: 0300 123 3393 or text 86463

What do I do now?
Once you have read this information sheet and have had any questions answered to your satisfaction, if you are still keen to participate in the study you will be prompted to electronically complete a consent form. Once your consent form is completed you can then complete the survey.

What if there are any problems?
We do not anticipate there to be any problems in taking part in this study. If you have any questions about the research or would appreciate the opportunity of results feedback (where you talk through any issues raised during this research) then please do email the lead researcher (Dr Rebecca Keyte – Rebecca.Keyte@bcu.ac.uk).

What if I have a complaint?
In the unlikely event of you having any complaints about any aspects of the study, we will do our best to answer these complaints. If you would prefer to speak to someone independent of the research team about your complaint then you can contact the Business, Law and Social Sciences Faculty Ethics Committee at Birmingham City University directly: blssethics@bcu.ac.uk

Will my taking part in the study be kept confidential?
Yes, we will follow ethical and legal practice and all information about you will be handed in confidence.

What happens if I have more questions?
If you do not understand something in this leaflet or have further questions you may contact the lead researcher via email (or social media) on: Rebecca.Keyte@bcu.ac.uk.

What happens now if I decide to participate?
If you decide to participate you will be asked to complete the electronic consent form. By completing it you acknowledge that you have understood the aims of the research, and what you are being asked to do.

What happens if I change my mind during the study?
You are free to withdraw your participation at any time, without providing a reason, to do this you can just close the webpage. You can also have your data withdrawn from the research within 14 days of completing the study. To withdraw your data you would need to contact Dr Rebecca Keyte (Rebecca.Keyte@bcu.ac.uk) stating your unique code that you will create at the beginning of this study (data will be anonymised therefore the unique code will be needed to identify and remove your data).

Who is organising and funding the study?
The study has been organised by Dr Rebecca Keyte and Prof. Helen Egan at Birmingham City University. These will not be paid for including you in this study. In addition, unfortunately we are unable to pay you for your participation.

Who has reviewed the study?
All research is looked at by an independent group of people called a Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed and given favourable opinion by the Business, Law and Social Sciences Ethics Committee at Birmingham City University.

Who can I contact about the study?
In the first instance any concerns or questions should be addressed to Dr Rebecca Keyte (Rebecca.Keyte@bcu.ac.uk) or Prof. Helen Egan (Helen.Egan@bcu.ac.uk). If you have any further concerns, you can contact the Business, Law and Social Sciences Faculty Ethics Committee at Birmingham City University directly: blssethics@bcu.ac.uk
If you have any questions, comments or concerns about how we use or handle your information please contact the Data Protection Officer at:

Data Protection Officer,
Information Management,
Legal Services,
Joseph Priestley Building,
Cardigan Street,
Birmingham,
B4 7RJ,
Email: informationmanagement@bcu.ac.uk, or call +44 (0)121 202 4597.

Participants can furthermore complain directly to the Information Commissioner at:
The Information Commissioner’s Office,
Wycliffe House,
Water Lane,
Wilmslow,
Cheshire,
SK9 5AF,
Further information is available at: www.ico.org.uk
Powered by QuestionPro